Principles of endocrine manipulation in the treatment of prostatic cancer.
D000726:Androgen Antagonists / Q000627:therapeutic use*; D000818:Animals; D002369:Castration; D003534:Cyproterone / Q000627:therapeutic use; D004967:Estrogens / Q000627:therapeutic use*; D005485:Flutamide / Q000627:therapeutic use; D007987:Gonadotropin-Releasing Hormone / Q000627:therapeutic use; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D009376:Neoplasms, Hormone-Dependent / Q000097:blood / Q000188:drug therapy / Q000601:surgery; D011372:Progestins / Q000627:therapeutic use; D011471:Prostatic Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000601:surgery; D051381:Rats; D013739:Testosterone / Q000097:blood
D000726:Androgen Antagonists; D004967:Estrogens; D011372:Progestins; D007987:Gonadotropin-Releasing Hormone; D013739:Testosterone; D005485:Flutamide; D007986:Luteinizing Hormone; D003534:Cyproterone